CR gas

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

CR gas
Image:CR gas structure.png
IUPAC name	dibenz[b,f][1,4]oxazepine
Identifiers
CAS number	257-07-8
SMILES	C1(C=CC=C2)=C2OC (C=CC=C3)=C3N=C1
Properties
Molecular formula	C13H9NO
Molar mass	195.22 g/mol
Density	x.xxx g/cm3
Melting point	73 °C
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references

CR gas or dibenzoxazepine, chemically dibenz[b,f][1,4]oxazepine, is an incapacitating agent and a lachrymatory agent. CR was developed by the British Ministry of Defence as a riot control agent in the late 1950s and early 1960s.

Physical properties

CR is a pale yellow crystalline solid with a pepper-like odour. It is slightly soluble in water and does not degrade in it. CR is usually presented as a microparticulate solid, in the form of suspension in a propylene glycol based liquid. Contrary to its common name, it is not actually a gas but is solid at room temperature.

It is chemically related to loxapine, a typical antipsychotic drug. CR is loxapine's parent compound. It was first synthesised in 1962.^[1]

CR gas is a lachrymatory agent (LA). CR gas is about 6-10 times stronger than CS gas. It causes very intense irritation and skin pain, namely around moist areas, blepharospasm causing temporary blindness, coughing and gasping for breath, and panic. It is capable of causing immediate incapacitation. It is a suspected carcinogen. The effect of CR is long-term and persistent. It can persist on surfaces for up to 60 days. These gases are usually fired in canisters (LACR) that heat up, producing an aerosol cloud at a steady rate.

Effects

CR gas is a lachrymatory agent (LA). CR gas is about 6-10 times stronger than CS gas. It causes very intense irritation and skin pain, namely around moist areas, blepharospasm causing temporary blindness, coughing and gasping for breath, and panic. It is capable of causing immediate incapacitation. It is a suspected carcinogen. These gases are usually fired in canisters (LACR) that heat up, producing an aerosol cloud at a steady rate. It is toxic, but less so than CS gas, by ingestion and exposure. However, it can be lethal in large quantities. In a poorly ventilated space, an individual may inhale a lethal dose within minutes. Death is caused by asphyxiation and pulmonary edema.

The effect of CR is long-term and persistent. CR can persist on surfaces, especially porous ones, for up to 60 days.

Treatment

While CS can be decontaminated with a large amount of water, use of water may exacerbate the effects of CR. Skin contaminated with CR gas may become extremely painful in contact with water for up to 48 hours after contamination. ^[2]

Medical treatment is mostly palliative. The contaminated clothing has to be removed. The eyes and skin can be washed, the eye pain can be alleviated with medications.^[3]

Use

In the late 1980s, CR was used in the townships in South Africa. It caused some fatalities, particularly among children.^[4]

Because of its alleged carcinogenic properties, the United States does not utilize CR for riot control.^[5]

• Military chemical compounds and their properties

References

1. CAS-Number and SMILES http://webbook.nist.gov/cgi/cbook.cgi?ID=257-07-8&Units=SI
2. ^  Higginbo R, Suschitzky H (1962). "Synthesis of Heterocyclic Compounds .2. Cyclisation of O-Nitrophenyl Oxygen Ethers". J Chem Soc: 2367-2370.
3. ^  http://www.zarc.com/english/tear_gases/crdibenzoxazepine.html
4. ^ Olajos EJ, Salem H (2001). "Riot Control Agents: Pharmacology, Toxicology, Biochemistry and Chemistry". J Appl Toxicol: 355-391.
5. ^  http://atiam.train.army.mil/soldierPortal/atia/adlsc/view/public/9655-1/FM/3-11.9/chap3.htm
6. ^  http://www.ainfos.ca/04/oct/ainfos00066.htmlde:Dibenzoxazepin

ja:CRガス

WikiDoc Help Menu Quick Start.. Get Started Here! How to Login How to Search Pages How to Start a New Page How to Edit a Page Cheat Sheet Editing basics Learning Basic Formatting How to make Links in WikiDoc & to External Sites How to Make Lists How to Ignoring Formatting Adding References or Footnotes to Articles Tracking Changes You Have Made How to Put an Article Into a Category When Multiple Topics Should Go To The Same Page (MI, Acute MI, AMI) Using Redirection Advanced editing How to Make Tables How to Insert Images and Other Media How to Add Video Help:How to Make Columns Web Colors How To Make Templates How to Move Pages Inserting Dynamic Dates and Times Inserting WikiDoc Statistics Editing the Table of Contents Communicating your edits Let others know what you changed: The importance of Edit Summaries Minor Edits Edit Conflicts Help Videos You Can Watch Getting Started Video

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .